Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care
Bangladesh Journal of Endocrinology and Metabolism · 2026-09 · 5 (3) · 336-340
DOI: 10.4103/bjem.bjem_17_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bangladesh Journal of Endocrinology and Metabolism, online erschienen am 15.05.2026. Verfasst von Ahmad Alam. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alam, A. (2026). Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care. Bangladesh Journal of Endocrinology and Metabolism, 5(3), 336-340. https://doi.org/10.4103/bjem.bjem_17_26
Vancouver
Alam A. Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care. Bangladesh Journal of Endocrinology and Metabolism. 2026;5(3):336-340. doi:10.4103/bjem.bjem_17_26
BibTeX
@article{Alam2026,
author = {Alam, Ahmad},
title = {Tirzepatide versus Semaglutide: Selecting the Right Agent for the Right Patient in Contemporary Metabolic Care},
journal = {Bangladesh Journal of Endocrinology and Metabolism},
year = {2026},
volume = {5},
number = {3},
pages = {336--340},
doi = {10.4103/bjem.bjem_17_26}
}
EUVIMED